LIPO OTC
Lipella Pharmaceuticals Inc.
1W: -0.0%
1M: +0.0%
3M: -99.4%
YTD: -99.7%
1Y: -99.9%
3Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-08-02
Earliest Filing
2025-04-07
Latest Filing
partner: 4
Counterparties (Filed by LIPO)
4 relationshipsCompanies named in LIPO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for At The Market Offering Agreement | 2025-04-07 | View |
| Nevada Agency and Transfer Company | — | partner | Warrant agent for the March Offering | 2025-03-18 | View |
| H.C. Wainwright & Co., LLC | — | partner | Exclusive placement agent for the private placement of pre-funded warrants and warrants. | 2023-10-26 | View |
| Bridgeway Development Corporation | — | partner | Lease agreement for office, manufacturing, and assembly space. | 2023-08-02 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-15 | Exhibits | View | |
| 2026-03-31 | Other Events | View | |
| 2026-02-04 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-10-21 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-10-09 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-09-18 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-25 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-20 | Notice of Delisting or Transfer; Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-06-16 | Other Events | View | |
| 2025-05-16 | Notice of Delisting or Transfer | View | |
| 2025-05-15 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-04-14 | Other Events | View | |
| 2025-04-09 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-04-07 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-03-18 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-03-11 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-03-03 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-02-24 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-02-11 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-01-13 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR